@weight/(@feet *12 + @inches )(@feet *12 + @inches)*703

BMI (Body Mass Index) is a formula used to estimate whether a person has a healthy weight in relation to their height. BMI is a useful tool for identifying if someone falls within the categories of underweight, normal weight, overweight, or obesity. However, it is important to understand that BMI does not directly measure body fat or overall health. It is merely a guide that helps assess the potential risk of weight-related health issues.

BMI Categories

Our medical weight loss plans are designed for adults with a body mass index (BMI) of 30 or higher (obesity) or 27 or higher (overweight) with at least one weight-related health condition.

Have you been prescribed a GLP-1 medication?

GLP-1 medications mimic the natural hormone glucagon-like peptide-1, which helps regulate blood sugar and appetite. These treatments enhance insulin secretion, slow digestion, and reduce hunger, making them effective for managing type 2 diabetes and promoting weight loss.

Have you been diagnosed with Diabetes Type 1?

Type 1 Diabetes is diagnosed by identifying high blood sugar levels combined with little to no insulin production. This is confirmed through tests that measure long-term blood sugar control and the presence of specific immune markers indicating an autoimmune attack on the pancreas.

Have you been diagnosed with Medullary Thyroid Cancer?

Medullary thyroid cancer (MTC) is a rare type of thyroid cancer that originates in the parafollicular C cells of the thyroid gland, which produce the hormone calcitonin. Elevated calcitonin levels often signal the presence of MTC. It may occur sporadically or as part of a genetic syndrome like Multiple Endocrine Neoplasia type 2 (MEN2). Early diagnosis and treatment, typically involving thyroidectomy, are crucial for managing the disease.

Have you been diagnosed with Multiple Endocrine Neoplasia?

Multiple Endocrine Neoplasia (MEN) is a rare genetic condition causing tumors in multiple endocrine glands. These tumors can be benign or malignant and commonly affect glands like the thyroid, parathyroid, pancreas, and adrenal glands. MEN is classified into types 1, 2A, and 2B, each with distinct glandular involvement and genetic mutations. Early detection is vital for management and preventing complications.

Have you been diagnosed with 

Chronic Pancreatitis?

Chronic pancreatitis is a long-term inflammation of the pancreas that leads to irreversible damage, affecting its ability to produce digestive enzymes and insulin. It often causes persistent abdominal pain, digestive issues, and malabsorption of nutrients. Common causes include prolonged alcohol use, genetic factors, and gallstones. Treatment focuses on managing pain, addressing nutritional deficiencies, and preventing complications.

Are you currently pregnant or breast feeding?

GLP-1 medications are generally not recommended for pregnant or breastfeeding individuals due to potential risks to the baby and the lack of sufficient research in these groups. During pregnancy, these medications may interfere with important hormonal and metabolic processes that support fetal development, and animal studies have raised concerns about potential harm. Similarly, it’s unclear if these medications pass into breast milk and how they might affect a nursing infant. Because of these uncertainties, healthcare providers typically advise avoiding GLP-1 medications during pregnancy and breastfeeding unless absolutely necessary.

Are you allergic to any medications?

It’s important to mention any medication allergies before starting GLP-1 treatment to ensure your safety. GLP-1 medications may contain active ingredients or additives that could trigger an allergic reaction. Severe reactions, such as anaphylaxis, can be life-threatening and require immediate medical attention. By disclosing your allergies, your healthcare provider can determine whether GLP-1 medications are safe for you or if alternative treatments are necessary.

List your allergies:

Informar sobre tus alergias es crucial porque ayuda a los proveedores de salud a garantizar tu seguridad al recetar medicamentos o tratamientos. Las reacciones alérgicas pueden variar de leves a graves, incluyendo condiciones potencialmente mortales como la anafilaxia. Al conocer tus alergias, los proveedores pueden evitar prescribir medicamentos o tratamientos que puedan desencadenar una reacción, asegurando que recibas una atención efectiva y segura.

Congratulations 🎉

Based on your results, you

Pre-qualify for our 

weight loss program!

Let's choose the best 

solution for your case 

based on your answers.

Compounded medications are not FDA-approved. The FDA does not verify the safety or effectiveness of compounded medications.*

Results depend on a calorie-reduced meal plan and an increase in physical activity. Individual results may vary. Consult with a healthcare provider to determine your eligibility and discuss a healthy and realistic target weight for you. Discontinuation of semaglutide treatment has been found to result in weight gain.

We are sorry 😢

Based on the information you've provided,   it appears you have been diagnosed with Type 1 Diabetes. 

Unfortunately, GLP-1 medications are not recommended for individuals with Type 1 diabetes due to specific treatment requirements.

People with Type 1 Diabetes generally shouldn’t take GLP-1 medications because these drugs are designed to stimulate insulin secretion in response to glucose, a process that requires functioning beta cells in the pancreas. In Type 1 Diabetes, the immune system destroys these beta cells, leaving little to no insulin production. As a result, GLP-1 medications are not effective in addressing the primary issue of insulin deficiency and cannot replace the need for insulin therapy. Additionally, their use in this population is not well-studied, and they may pose unnecessary risks without offering significant benefits.

We are Sorry 😢

Based on the information you've provided, it appears you have been diagnosed with thyroid cancer. 

Unfortunately, GLP-1 medications are not recommended for individuals with a history of thyroid cancer due to specific treatment guidelines.

People with thyroid cancer, particularly medullary thyroid cancer (MTC), or a history of it should avoid GLP-1 medications because these drugs have been associated with an increased risk of thyroid C-cell tumors in animal studies. Although this risk has not been confirmed in humans, GLP-1 medications like Semaglutide and Liraglutide carry warnings due to this potential link. Individuals with a personal or family history of MTC or conditions like Multiple Endocrine Neoplasia type 2 (MEN2) are at higher risk, and using GLP-1 medications could exacerbate concerns about thyroid tumor development. This precaution helps protect patients from potential harm.

We are Sorry 😢

Based on the information you've provided, it appears you have been diagnosed with multiple endocrine neoplasia. 

Unfortunately, GLP-1 medications are not recommended for individuals with endocrine neoplasia due to specific treatment guidelines.

Patients with endocrine neoplasia, particularly Multiple Endocrine Neoplasia type 2 (MEN2) or a history of medullary thyroid cancer (MTC), should avoid GLP-1 treatments because these medications are linked to an increased risk of thyroid C-cell tumors in animal studies. While this risk has not been definitively proven in humans, it is a significant concern for individuals predisposed to these types of cancers. GLP-1 medications like Semaglutide and Liraglutide carry warnings about this potential risk, making them unsuitable for individuals with a personal or family history of MEN2 or MTC. This precaution helps ensure the safety of patients with a higher risk of thyroid malignancies.

We are Sorry 😢

Based on the information you've provided, it appears you have been diagnosed with chronic pancreatitis.

Unfortunately, GLP-1 medications are not recommended for individuals with chronic pancreatitis due to specific treatment requirements.

People with chronic pancreatitis generally shouldn’t take GLP-1 medications because these drugs may increase the risk of exacerbating pancreatic issues. GLP-1 treatments work by stimulating the pancreas to produce insulin, which can strain an already damaged or inflamed pancreas. This additional stress may worsen symptoms, lead to further inflammation, or increase the risk of complications like pancreatic insufficiency or even pancreatitis flare-ups. Additionally, GLP-1 medications are associated with a potential risk of pancreatitis, making them unsuitable for individuals with a history of chronic pancreatic conditions.

We are sorry 😢

Based on the information you've provided, it appears that you are currently pregnant or breastfeeding. 

Unfortunately, GLP-1 medications are not recommended during pregnancy or breastfeeding due to safety concerns and specific treatment guidelines.

GLP-1 medications are not primarily known to affect fertility in men or women. However, weight loss and improved metabolic health associated with GLP-1 treatments may have indirect positive effects on fertility, particularly for individuals with conditions like polycystic ovary syndrome (PCOS) or obesity-related fertility issues. In men, better blood sugar control and weight loss might improve overall reproductive health.

That said, there is limited research specifically on the direct effects of GLP-1 medications on fertility. If you are planning to conceive or have concerns about fertility, it’s important to discuss the use of GLP-1 medications with a healthcare provider.